Faeth Therapeutics, Inc. SEC filings
Every EDGAR filing for Faeth Therapeutics, Inc. (SNSE), newest first, with AI summaries and stories.
- Ticker
- SNSE
- CIK
- 1829802
- Latest filing
- Sep 17
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-KFaeth Therapeutics, Inc.SNSELIVE ROUTINE4Faeth Therapeutics, Inc.SNSELIVE 2 insider filings
Karen H Vousden, insider filing for SNSE
Show all 2
- 4Insider filing for SNSE
- 3New insider at SNSE
Karen H Vousden, reporting
ROUTINESCHEDULE 13G/AFaeth Therapeutics, Inc.SNSELIVE 3 13G filings
Ownership stake disclosure by Caligan Partners LP (amended)
Show all 3
- SCHEDULE 13G/AOwnership stake disclosure (amended)
- SCHEDULE 13G/AOwnership stake disclosure (amended)
- SCHEDULE 13GOwnership stake disclosure
Caligan Partners LP, filed by
ROUTINESCHEDULE 13G/AFaeth Therapeutics, Inc.SNSELIVE Ownership stake disclosure by STEMPOINT CAPITAL LP (amended)
STEMPOINT CAPITAL LP, filed by
ROUTINE144Faeth Therapeutics, Inc.SNSELIVE Cambrian BioPharma Inc, planned sale of SNSE shares
Cambrian BioPharma Inc, reporting
NOTABLE10-QFaeth Therapeutics, Inc.SNSELIVE ROUTINE8-KFaeth Therapeutics, Inc.SNSELIVE ROUTINE3Faeth Therapeutics, Inc.SNSELIVE Vinod Khosla, new insider at SNSE
Vinod Khosla, reporting · VK Services, LLC, reporting · +4 more
ROUTINE8-KFaeth Therapeutics, Inc.SNSELIVE ROUTINE4Faeth Therapeutics, Inc.SNSELIVE 2 insider filings
Anand Kiran Parikh, insider filing for SNSE
Show all 2
- 4Insider filing for SNSE
- 4Insider filing for SNSE
Anand Kiran Parikh, reporting
ROUTINE4Faeth Therapeutics, Inc.SNSELIVE Brian C Stephenson, insider filing for SNSE
Brian C Stephenson, reporting
ROUTINE4Faeth Therapeutics, Inc.SNSELIVE Brian C Stephenson, insider filing for SNSE
Brian C Stephenson, reporting
ROUTINE4Faeth Therapeutics, Inc.SNSELIVE 2 insider filings
Brian C Stephenson, insider filing for SNSE
Show all 2
- 4Insider filing for SNSE
- 4Insider filing for SNSE
Brian C Stephenson, reporting
ROUTINE3Faeth Therapeutics, Inc.SNSELIVE Brian C Stephenson, new insider at SNSE
Brian C Stephenson, reporting
ROUTINESCHEDULE 13GFaeth Therapeutics, Inc.SNSELIVE 2 13G filings
Ownership stake disclosure by SUVRETTA CAPITAL MANAGEMENT, LLC
Show all 2
- SCHEDULE 13GOwnership stake disclosure
- SCHEDULE 13GOwnership stake disclosure
SUVRETTA CAPITAL MANAGEMENT, LLC, filed by
ROUTINE8-KFaeth Therapeutics, Inc.SNSELIVE ROUTINES-3ASRFaeth Therapeutics, Inc.SNSELIVE ROUTINE4Sensei Biotherapeutics, Inc.SNSELIVE 6 insider filings
Saira Ramasastry, insider filing for SNSE
Show all 6
- 4Insider filing for SNSE
- 4Insider filing for SNSE
- 3New insider at SNSE
- 4Insider filing for SNSE
- 3New insider at SNSE
- 4/AInsider filing for SNSE (amended)
Saira Ramasastry, reporting
ROUTINE8-KSensei Biotherapeutics, Inc.SNSELIVE ROUTINEEFFECTSensei Biotherapeutics, Inc.SNSELIVE ROUTINE4Sensei Biotherapeutics, Inc.SNSELIVE 3 insider filings
Christopher Gerry, insider filing for SNSE
Show all 3
- 4Insider filing for SNSE
- 4Insider filing for SNSE
- 4Insider filing for SNSE
Christopher Gerry, reporting
ROUTINES-3/ASensei Biotherapeutics, Inc.SNSELIVE ROUTINE8-KSensei Biotherapeutics, Inc.SNSELIVE ROUTINESCHEDULE 13G/ASensei Biotherapeutics, Inc.SNSELIVE Ownership stake disclosure by MILLENNIUM MANAGEMENT LLC (amended)
MILLENNIUM MANAGEMENT LLC, filed by
ROUTINE10-K/ASensei Biotherapeutics, Inc.SNSELIVE ROUTINES-3/ASensei Biotherapeutics, Inc.SNSELIVE ROUTINE4Sensei Biotherapeutics, Inc.SNSELIVE 2 insider filings
Cambrian BioPharma Inc, insider filing for SNSE
Show all 2
- 4Insider filing for SNSE
- 4Insider filing for SNSE
Cambrian BioPharma Inc, reporting
ROUTINEDEFA14ASensei Biotherapeutics, Inc.SNSELIVE ROUTINE8-KSensei Biotherapeutics, Inc.SNSELIVE ROUTINEDEFA14ASensei Biotherapeutics, Inc.SNSELIVE ROUTINE8-KSensei Biotherapeutics, Inc.SNSELIVE ROUTINE4Sensei Biotherapeutics, Inc.SNSELIVE 4 insider filings
Israel A Englander, insider filing for SNSE
Show all 4
- 4Insider filing for SNSE
- 4Insider filing for SNSE
- 4Insider filing for SNSE
- 3New insider at SNSE
Israel A Englander, reporting · MILLENNIUM MANAGEMENT LLC, reporting · +2 more
ROUTINESCHEDULE 13GSensei Biotherapeutics, Inc.SNSELIVE Ownership stake disclosure by MILLENNIUM MANAGEMENT LLC
MILLENNIUM MANAGEMENT LLC, filed by